학술논문
Circulating Tumor DNA Integrated with Interim [18F]FDG PET Is Highly Effective in Predicting Outcome of Relapsed/Refractory Classical Hodgkin Lymphoma Treated with the Begev Regimen
Document Type
Abstract
Author
Source
In Blood 23 November 2021 138 Supplement 1:3504-3504
Subject
Language
ISSN
0006-4971